Supplemental Materials and Methods.

Scoring system for sinusoidal obstructive syndrome (SOS).
Scoring was performed by adapting two human scoring systems, as described in Rubbia-Brandt et al [1] and Stevenson et al [2] . Steatosis was also assessed based on a proposed NAFLD scoring system in rodent models by Liang et al [3] and additional parameters were evaluated according to the schema described below.
1. Sinusoidal dilation: 0=absent; 1=mild (centrilobular involvement limited to 1/3 of lobule); 2=moderate (centrilobular involvement extending in 2/3 of lobule); 3=severe (complete lobular involvement or centrilobular involvement extending to adjacent lobules with bridging congestion). 2. Venous obstruction: 0=absent; 1=present, partial obstruction of central venule(s); 2=present, total occlusion of central venule(s). 3. Atrophy: 0=absent; 1=present. 4. Apoptosis (single cell acidophil bodies): 0=absent; 1=present. 5. Centrivenular regional necrosis: 0=absent; 1=>0-5%; 2=>5-33%; 3=>33-66%; 4=>66%. 6. Microvesicular steatosis: 0=absent; 1=minimal (<5%), 2=mild (>5-33%), 3=moderate (>33-66%);
4=severe (>66%). 7. Small droplet steatosis: 0=absent; 1=minimal (<5%), 2=mild (>5-33%), 3=moderate (>33-66%); 4=severe (>66%). 8. Large droplet steatosis: 0=absent; 1=minimal (<5%), 2=mild (>5-33%), 3=moderate (>33-66%); 4=severe (>66%). 9. Clear cell changes: clear cytoplasm, mild cellular swelling, with or without flocculant cytoplasm or fine cytoplasmic granular contents; 0=absent; 1=minimal (<5%), 2=mild (>5-33%), 3=moderate (>33-66%); 4=severe (>66%). 10. Portal inflammation: 0=absent; 1 mild, 2=moderate; 3=severe. 11. Lobular inflammation: 0=absent; 1=minimal (1-2 foci, 20x), 2=mild (3-6 foci, 20x), 3=moderate (7-12 foci, 20x); 4=severe (>12 foci, 20x); 5=diffuse (abundant, marked panlobular). 12. Interface activity: 0=absent; 1=mild (focal, few portal areas); 2=mild/moderate (focal, most portal areas); 3=moderate (continuous, <50% of portal tracts); 3=severe (continuous, >50% of portal tracts).
Analysis of the APAP protein adducts
APAP-protein adducts were measured as previously described, with modifications [4, 5] . Briefly, liver tissues were homogenized in 1x phosphate-buffered saline using a Fisherbrand Bead Ruptor homogenizer. The homogenates were then centrifuged at 12,000 g for 5 min to pellet cell debris, and two aliquots of supernatant were collected. One aliquot was passed through a size-exclusion column to purify protein. The protein was then digested by a mixture of proteases to liberate APAP-bound cysteine residues (APAP-CYS). The proteases were then precipitated with trichloroacetic acid and filtered out.
Finally, APAP-CYS was measured in the filtrate using HPLC separation with electrochemical detection.
The second aliquot was used for protein measurement by a bicinchoninic acid assay method, and APAP-CYS was normalized to protein.
Glutathione analysis
Glutathione was measured using a modified Tietze assay [6] . Briefly, liver tissue was homogenized in 3% sulfosalicylic acid. One aliquot was diluted in a solution containing N-ethylmaleimide (NEM) to mask reduced glutathione (GSH) and facilitate measurement of oxidized glutathione (GSSG), while another was diluted in 0.1 M HCl for measurement of total (GSH+GSSG) glutathione. After removal of NEM by solid phase extraction with a C18 column, glutathione was measured in both aliquots using a colorimetric glutathione reductase cycling detection method.
